Acute myeloid leukemia: advances in diagnosis and classification (Q38099426)

28 August 2017

Acute myeloid leukemia: advances in diagnosis and classification (English)

1 reference

28 August 2017

1 reference

acute myeloid leukemia

1 reference

R P Hasserjian

1

1 reference

28 August 2017

1 June 2013

1 reference

International Journal of Laboratory Hematology

28 August 2017

1 reference

28 August 2017

35

1 reference

28 August 2017

3

1 reference

28 August 2017

358-366

1 reference

Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Clinical and pathologic features of secondary acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

The natural history and treatment outcome of blast phase BCR-ABL- myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Clonal architecture of secondary acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not oth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12081

21 January 2018

Identifiers

DOI

10.1111/IJLH.12081

1 reference

release_xg6b63r3vre6zo4mplv4avzarm

28 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xg6b63r3vre6zo4mplv4avzarm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

23590662

1 reference

PubMed ID

23590662